Evidence map›Paper›PMID 39166784›Full record

ArticleElectrophoresis2025

Investigation of sample handling steps for accurate heparan sulphate disaccharide analysis using HPLC-MS.

Domonkos Pál, Gábor Tóth, Lilla Turiák

Abstract read
In one paragraph

Article in Electrophoresis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Domonkos PálMTA-TTK Lendület (Momentum) Glycan Biomarker Research Group, Institute of Organic Chemistry, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.ORCID 0000-0002-0226-0004
Gábor TóthBMC Department of Chemistry, Uppsala University, Uppsala, Sweden.ORCID 0000-0003-1428-7906
Lilla TuriákMTA-TTK Lendület (Momentum) Glycan Biomarker Research Group, Institute of Organic Chemistry, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary.ORCID 0000-0002-2139-8156

Funding

Magyar Tudományos Akadémia LP-2023-19/2023National Research, Development and Innovation Office OTKA FK 131603
6 · The paper itself

Abstract

Heparan sulphates (HSs), a specific class of glycosaminoglycans (GAGs), are important participants of cellular signalling. Analytical characterization of GAGs requires a complex sample preparation workflow. Although a detailed stability and recovery study is available for the chondroitin sulphate GAG class, the literature concerning HS is incomplete in this regard. Therefore, our aim was to systematically investigate various parameters that could potentially influence the stability and recovery of HS samples when performing disaccharide analysis using high-performance liquid chromatography-mass spectrometry. First, effects concerning vacuum evaporation and freezing were investigated. Next, the storage stability of the HS disaccharides was analysed under several conditions such as temperature, pH, digestion buffers, injection solvents and storage vessels. We have identified several critical parameters influencing the stability and recovery of HS disaccharides. We concluded that major sample loss is expected when Tris-HCl is used as digestion buffer, followed by vacuum evaporation at elevated temperatures, or samples are stored under alkaline conditions. Following the practical considerations of this paper can contribute to increasing the reliability of future analytical measurements.

Indexed as

DisaccharidesHeparan SulfateMass SpectrometrySpecimen HandlingChromatography, High Pressure LiquidHydrogen-Ion ConcentrationLiquid Chromatography-Mass SpectrometryReproducibility of ResultsTemperatureDisaccharidesHeparan Sulfateheparan sulphatehigh‐performance liquid chromatographymass spectrometryrecoverystability

Identifiers

PMID39166784
PMCPMC12273894

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.